Preventive Episodic Migraine Treatment
10. Ryan RE (1984) Comparative study of nadolol and propranolol in prophylactic treatment of migraine. Am Heart J 108:1156–1159 11. Cortelli P, Sacquegna T, Albani F, Baldrati A, D’Alessandro R,…
Epidemiology of Headache
References Number of participants Period Age Headache Migraine TTH Eurolight Project (2014) Steiner et al. [39] 8271 (9 countries) 1 year (unadjusted) 18–65 79.6 % 22.2 % (definite) 30.8…
Headache Classification
A. Any headache (H) fulfilling criterion C B. Another disorder scientifically documented to be able to cause H has been diagnosed C. Evidence of causation demonstrated by at least two…
Placebo and Nocebo Effects
Condition Placebo Placebo in children 1. Migraine 1.1 Symptomatic treatment a Analgesics 9 % (7–17) 37–53 % Triptans 6.1 ± 84.4 % (5–17) 28–65 % TMS 67 % 1.2. Prophylactic treatment b…
Treatment of Acute Migraine Attacks
Migraine without aura Indicators Migraine without aura and its indicators, 1.1 [G43.0/N89] Migraine without aura A At least five attacks fulfilling criteria B–D B Headache attacks lasting 4–72 h C…
Review of Existing Guidelines
Austria See also Germany Belgium Guideline for migraine treatment in primary care (Internet) Guideline for the management of chronic migraine [22] Croatia Evidence-based guidelines for treatment of primary headaches [27]…
Pharmacogenomics in Neurology
Pharmacogenomics in Neurology Francis M. Gengo, PharmD, FCP, & Michelle M. Rainka, PharmD LEARNING OBJECTIVES • Review specific neurological disease states and the pharmacogenomics of these. • Discuss how pharmacogenomics…
